The company aims to address the deficiency of branched fats in preterm and formula-fed infants, which negatively impacts gut health and immunity. By supplying the global pharmaceutical, infant formula, and supplement market with their proprietary branched fat active ingredients, Vernx Biotechnology is dedicated to providing science-based medical foods that enhance gastrointestinal health.